AWA
TEVA icon

Aaron Wealth Advisors’s Teva Pharmaceuticals TEVA Stock Holding History

Aaron Wealth Advisors’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$421K Buy
12,412
+537
+5% +$17.9K 0.02% 478
2026
Q1 		$358K Buy
11,875
+1,600
+16% +$51.5K 0.02% 494
2025
Q4 		$321K Buy
+10,275
New +$253K 0.02% 553
2022
Q2 		– Sell
-603
Closed -$5.66K – 779
2022
Q1 		$5.66K Buy
+603
New +$5.03K ﹤0.01% 856

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Aaron Wealth Advisors's TEVA Position: Q2 2026 in Review

Aaron Wealth Advisors increased its Teva Pharmaceuticals (TEVA) stake by 4.5% in Q2 2026, buying an estimated $17.9K and bringing the position to 12,412 shares worth $421K. The position accounts for 0.02% of the portfolio, ranked #478.

Aaron Wealth Advisors first reported a position in TEVA in Q1 2022 and has held it in 4 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Aaron Wealth Advisors held 12,412 shares of Teva Pharmaceuticals worth $421K as of Q2 2026.
  • Aaron Wealth Advisors bought 537 Teva Pharmaceuticals shares in Q2 2026, an estimated $17.9K.
  • Teva Pharmaceuticals made up 0.02% of Aaron Wealth Advisors's portfolio in Q2 2026, its #478 holding.
  • Aaron Wealth Advisors first reported a position in Teva Pharmaceuticals in Q1 2022 and has held it in 4 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Aaron Wealth Advisors's 13F filing for Q2 2026, filed 16 Jul 2026.